|
Volumn 18, Issue 3, 2009, Pages 1013-
|
Diagnosing gastrointestinal stromal tumors before the year 2000
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IMATINIB;
ANTINEOPLASTIC AGENT;
PIPERAZINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
CANCER DIAGNOSIS;
CANCER PATIENT;
CANCER SURVIVAL;
DIAGNOSTIC ERROR;
GASTROINTESTINAL STROMAL TUMOR;
HISTOPATHOLOGY;
HUMAN;
LETTER;
MESENCHYMOMA;
PRIORITY JOURNAL;
RACE;
SOCIAL STATUS;
TREATMENT OUTCOME;
TUMOR CLASSIFICATION;
CANCER REGISTRY;
ETHNOLOGY;
FEMALE;
HEALTH CARE DISPARITY;
MALE;
METASTASIS;
MIDDLE AGED;
MORTALITY;
NOTE;
SOCIOECONOMICS;
SURVIVAL RATE;
UNITED STATES;
ANTINEOPLASTIC AGENTS;
FEMALE;
GASTROINTESTINAL STROMAL TUMORS;
HEALTHCARE DISPARITIES;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
PIPERAZINES;
PYRIMIDINES;
SEER PROGRAM;
SOCIOECONOMIC FACTORS;
SURVIVAL RATE;
UNITED STATES;
|
EID: 64549089702
PISSN: 10559965
EISSN: None
Source Type: Journal
DOI: 10.1158/1055-9965.EPI-08-0865 Document Type: Letter |
Times cited : (3)
|
References (5)
|